Literature DB >> 8573395

Structural modification of serum vitamin D3-binding protein and immunosuppression in AIDS patients.

N Yamamoto1, V R Naraparaju, S M Srinivasula.   

Abstract

A serum glycoprotein, vitamin D3-binding protein (Gc protein), can be converted by beta-galactosidase of stimulated B lymphocytes and sialidase of T lymphocytes to a potent macrophage-activating factor (MAF), a protein with N-acetylgalactosamine as the remaining sugar moiety. Thus, Gc protein is a precursor for MAF. Treatment of purified Gc protein with immobilized beta-galactosidase and sialidase generates an extremely high-titered MAF (GcMAF). When peripheral blood monocytes/macrophages of 46 HIV-infected patients were treated with GcMAF (100 pg/ml), the monocytes/macrophages of all patients were efficiently activated. However, the MAF precursor activity of plasma Gc protein was low in 16 (35%) of of these patients. Loss of the MAF precursor activity appeared to be due to deglycosylation of plasma Gc protein by alpha-N-acetylgalactosaminidase found in the patient blood stream. Levels of plasma alpha-N-acetylgalactosaminidase activity in individual patients had an inverse correlation with the MAF precursor activity of their plasma Gc protein. Thus, precursor activity of Gc protein and alpha-N-acetylgalactosaminidase activity in patient blood can serve as diagnostic and prognostic indices.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8573395     DOI: 10.1089/aid.1995.11.1373

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.

Authors:  Kalvin J Gregory; Bing Zhao; Diane R Bielenberg; Sami Dridi; Jason Wu; Weihua Jiang; Bin Huang; Steven Pirie-Shepherd; Michael Fannon
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

2.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Authors:  Nobuto Yamamoto; Hirofumi Suyama; Nobuyuki Yamamoto
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

3.  Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice.

Authors:  Oliver Kisker; Shinya Onizuka; Christian M Becker; Michael Fannon; Evelyn Flynn; Robert D'Amato; Bruce Zetter; Judah Folkman; Rahul Ray; Narasimha Swamy; Steven Pirie-Shepherd
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

4.  Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: Lesson learned from HIV.

Authors:  Lucrezia Spadera; Maria Spadera
Journal:  Med Hypotheses       Date:  2020-09-24       Impact factor: 1.538

5.  Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-N-acetylgalactosaminidase-like activities in the pH 5 to 8 region.

Authors:  Simon P J Albracht; Johannes van Pelt
Journal:  BBA Clin       Date:  2017-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.